Parathyroid hormone and the risk of incident hypertension: The Atherosclerosis Risk in Communities study

Lu Yao, Aaron R. Folsom, James S. Pankow, Elizabeth Selvin, Erin D. Michos, Alvaro Alonso, Weihong Tang, Pamela L. Lutsey

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Background: Recent evidence suggests that parathyroid hormone (PTH) has effects on vascular smooth muscle cells, the rennin-angiotensin system and kidney function, but less is known about its role in the development of hypertension. The distribution of serum PTH also varies by race. Methods and results: Therefore, we examined the relation between PTH and incident hypertension and tested for interaction by race among 7504 Atherosclerosis Risk in Communities participants (1264 black, 6240 white, median age 56 years) without initial hypertension in 1990-1992. During a median follow-up of 6 years, 1487 white and 509 black participants developed hypertension. In the overall study population, PTH was not associated with incident hypertension after adjustment for demographics and behavioral risk factors [hazard ratio highest vs. lowest quintiles, 95% confidence interval: 1.11 (0.96-1.28); P for linear trend 0.02]. Although the interaction was not statistically significant (P = 0.60), there was some evidence that the PTH-hypertension association differed by race. Among blacks, PTH was positively associated with incident hypertension, independent of demographics, and behavioral risk factors (P for linear trend 0.003). Among whites, PTH was not associated with hypertension risk. Results were similar when comparing participants with elevated versus nonelevated PTH (≥65 vs. <65 pg/ml): hazard ratio in blacks: 1.24 (1.02-1.54); hazard ratio in whites: 0.95 (0.78-1.16). Conclusions: In this large community-based cohort, PTH levels, overall, were not independently associated with the risk of hypertension. However, we found some evidence that PTH may be associated with hypertension in blacks. Future research should continue to explore potential race differences in the PTH-hypertension association.

Original languageEnglish (US)
Pages (from-to)196-203
Number of pages8
JournalJournal of hypertension
Issue number2
StatePublished - Feb 1 2016

Bibliographical note

Funding Information:
The authors thank the staff and participants of the ARIC study for their important contributions. Source of funding: The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN26820 1100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN26 8201100012C). Measurement of PTH and some of the related biomarkers was supported through National Institutes of Health grants R01 HL103706, R01 NS072243, and R01 DK089174. Previous presentation: Poster presentation at the American Heart Association Epidemiology and Prevention/Nutrition, Physical Activity and Metabolism Scientific Sessions, Baltimore, MD, March 3-6, 2015.

Publisher Copyright:
Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.


  • Cohort study
  • Hypertension
  • Parathyroid hormone
  • Race disparity


Dive into the research topics of 'Parathyroid hormone and the risk of incident hypertension: The Atherosclerosis Risk in Communities study'. Together they form a unique fingerprint.

Cite this